MedPath

Tear Film Innovations iLux Safety Study

Not Applicable
Completed
Conditions
Evaporative Dry Eye
Meibomian Gland Dysfunction
Interventions
Device: iLux 2020 System
Registration Number
NCT03055897
Lead Sponsor
Tear Film Innovations, Inc.
Brief Summary

The objective of this study was to measure the temperature of the cornea and surrounding eye tissue temperature immediately after heating the eyelids with the iLux device using the protocol treatment profile. Eligible participants attended one treatment visit, with follow-up one day following the procedure.

Detailed Description

Alcon Research, LLC, acquired TearFilm Innovations, Inc., in December 2018. This study was designed and conducted by TearFilm Innovations, Inc. The study results were collected, analyzed, and provided by TearFilm Innovations, Inc., to Alcon Research, LLC.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Sign written informed consent prior to study participation

Key

Exclusion Criteria
  • History of ocular surgery within 1 year
  • Active ocular infection
  • Ocular surface abnormality; lid surface abnormalities
  • Pregnant, nursing or not utilizing adequate birth control measures
  • Other protocol-specified exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
iLux 2020 SystemiLux 2020 SystemMeibomian gland treatment (Day 0) according to instructions for use (IFU)/User Manual
Primary Outcome Measures
NameTimeMethod
Mean Overall Maximum Temperature of the Cornea and Surrounding Eye Tissue Immediately Post-treatmentDay 0 immediately post-treatment

Post-heating values were obtained by infrared camera for each participant. The cornea, the eyelid, and the surface tissue surrounding the eye were measured. Both eyes contributed to the analysis. No formal hypothesis testing was specified.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

TearFilm Innovations Investigative Site

🇺🇸

Encinitas, California, United States

© Copyright 2025. All Rights Reserved by MedPath